These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9743569

  • 21. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C, Condé F, Brouillet E, Mittoux V, Beal MF, Bloch G, Hantraye P.
    Neurobiol Dis; 1999 Aug; 6(4):259-68. PubMed ID: 10448053
    [Abstract] [Full Text] [Related]

  • 22. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD, Rodrigues CM, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC.
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [Abstract] [Full Text] [Related]

  • 23. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?
    Del Río P, Montiel T, Chagoya V, Massieu L.
    Neuroscience; 2007 Jun 08; 146(4):1561-70. PubMed ID: 17490821
    [Abstract] [Full Text] [Related]

  • 24. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST, Chu K, Park JE, Hong NH, Im WS, Kang L, Han Z, Jung KH, Kim MW, Kim M.
    J Neurochem; 2008 Mar 08; 104(5):1190-200. PubMed ID: 17976163
    [Abstract] [Full Text] [Related]

  • 25. Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats.
    Binienda Z, Virmani A, Przybyla-Zawislak B, Schmued L.
    Neurosci Lett; 2004 Sep 02; 367(2):264-7. PubMed ID: 15331167
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
    Kumar P, Kumar A.
    Indian J Exp Biol; 2009 Sep 02; 47(9):715-22. PubMed ID: 19957883
    [Abstract] [Full Text] [Related]

  • 28. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, Jung SH, Kim MW, Chu K, Kim M.
    Brain Res; 2008 Feb 15; 1194():130-7. PubMed ID: 18166168
    [Abstract] [Full Text] [Related]

  • 29. Experimental basis for the putative role of GluR6/kainate glutamate receptor subunit in Huntington's disease natural history.
    Diguet E, Fernagut PO, Normand E, Centelles L, Mulle C, Tison F.
    Neurobiol Dis; 2004 Apr 15; 15(3):667-75. PubMed ID: 15056475
    [Abstract] [Full Text] [Related]

  • 30. Brain region specificity of 3-nitropropionic acid-induced vulnerability of neurons involves cytochrome c oxidase.
    Singh S, Misiak M, Beyer C, Arnold S.
    Neurochem Int; 2010 Oct 15; 57(3):297-305. PubMed ID: 20600440
    [Abstract] [Full Text] [Related]

  • 31. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I, Collado JA, Medina FJ, Peña J, Del C Muñoz M, Jimena I, Franco F, Rueda I, Feijóo M, Muntané J, Montilla P.
    Neurochem Int; 2006 Apr 15; 48(5):367-73. PubMed ID: 16420966
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).
    Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, Jellinger KA, Poewe W, Wenning GK.
    Acta Neuropathol; 2003 Aug 15; 106(2):157-66. PubMed ID: 12764627
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Enhanced expression of C/EBP homologous protein (CHOP) precedes degeneration of fibrocytes in the lateral wall after acute cochlear mitochondrial dysfunction induced by 3-nitropropionic acid.
    Fujinami Y, Mutai H, Kamiya K, Mizutari K, Fujii M, Matsunaga T.
    Neurochem Int; 2010 Feb 15; 56(3):487-94. PubMed ID: 20026213
    [Abstract] [Full Text] [Related]

  • 36. Paradoxical increase in 3-nitropropionic acid neurotoxicity by alpha-phenyl-tert-butyl-nitrone, a spin-trapping agent.
    Lan MY, Chang YY, Chen SS, Wu HS, Chen WH, Liu JS.
    Chang Gung Med J; 2005 Feb 15; 28(2):77-84. PubMed ID: 15880982
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.
    Blum D, Hemming FJ, Galas MC, Torch S, Cuvelier L, Schiffmann SN, Sadoul R.
    Neurosci Lett; 2004 Sep 30; 368(3):309-13. PubMed ID: 15364417
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
    Dalbem A, Silveira CV, Pedroso MF, Breda RV, Werne Baes CV, Bartmann AP, da Costa JC.
    Brain Res; 2005 Jun 21; 1047(2):148-58. PubMed ID: 15901483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.